Tragic Loss: Daughter's Numb Arm Leads to Sudden Death

A Tragic Turn: The Story of Alicia-Adele Axiak

It's hard to grasp the brutal reality of losing a child, especially when that loss comes so swiftly. The experience of Amanda Axiak, whose daughter Alicia-Adele was diagnosed with an aggressive brain tumor, underscores a grim urgency for better research funding and awareness around pediatric brain cancers. Within merely two weeks of showing a seemingly innocuous symptom, this vibrant 11-year-old would be gone, leaving her family and community in utter shock and grief. In April 2025, Alicia-Adele, a fit and active girl from Caerphilly, woke up reporting a peculiar numbness in her arm. She’d spent the week engaged in activities she loved: netball, gymnastics, and preparing for a dance competition. It wasn't until her symptoms progressed to include numbness in her face and leg that the gravity of her situation became apparent. As Amanda recounted, they initially dismissed Alicia’s discomfort, thinking it might be fatigue from her busy schedule. However, when alertness turned urgent after a call to their GP, Amanda was advised that they needed to head straight to the hospital. A fruitful life, filled with sports and laughter, took a devastating turn. An MRI scan revealed what they dreaded most: a diffuse midline glioma, known commonly as DIPG—an inoperable and incurable brain tumor. The diagnosis came on April 12, 2025, just days after that ominous numbness appeared. Amanda has described this harrowing period as one that "ripped our world apart entirely." How can a healthy, active child be struck down so unexpectedly? It raises critical questions about the gaps in pediatric healthcare and the urgent need for increased investment in cancer research. Just a month prior, Alicia-Adele had a routine examination and showed no signs of wellness issues—no headaches, no unexplained fevers. Amanda's experience highlights a broader, painful truth: pediatric brain tumors can emerge with little to no warning. The family's nightmare culminated 13 days after the initial diagnosis, when Alicia passed away peacefully surrounded by her family, a tragic reminder of how fragile life can be. Now, Amanda Axiak is committed to ensuring that Alicia’s story isn’t forgotten or overlooked in the ongoing battle for better funding and awareness of pediatric brain cancer research, emphasizing that more must be done so that other families don’t share her heartbreaking tale. The Welsh government has publicly committed to improving cancer research and access to clinical trials, but for families like Amanda's, these promises feel painfully delayed against the backdrop of their immense loss.### A Legacy of Advocacy: Turning Grief into Action The tragic loss of young Alicia has sparked not only an outpouring of grief but also a vigorous campaign for change in brain tumour research funding. Her mother, Amanda Maria Axiak, has launched Alicia-Adele's Angels, a group dedicated to raising awareness and financial support for brain tumour research. In stark contrast to the brutal realities facing families dealing with this disease, Alicia's story exemplifies the urgent need for increased funding—especially considering that brain tumours are the leading cause of cancer deaths among children and those under 40 in Wales. Amanda's sentiment echoes the frustrating statistics: since 2002, brain cancer research has received a paltry 1% of UK cancer funding, which is simply unacceptable given the gravity of the issue. Life expectancy for those diagnosed with brain tumours remains dismal, with a mere 17.2% of patients in Wales surviving five years or more after diagnosis, compared to a much higher 61.5% survival rate across all cancers. These numbers should alarm anyone paying attention to public health, yet they continue to be overlooked in discussions around cancer funding. Amanda's heartbreak fuels her determination; she refuses to let her daughter's death be forgotten. Events like the Caerphilly 10K have raised around £7,500 so far, a vital step toward accumulating the resources needed for future research. As she puts it, raising awareness and funding isn't just a personal mission; it's critical so that future patients are not left behind, echoing Alicia's own dreams of becoming a paediatrician and helping other children. What stands out here is how Amanda channels her grief into activism. Her words resonate: "Every parent thinks their child is perfect, of course they do, but she was. She was an absolute angel, always cared for everyone." Such a deep-seated understanding of empathy and kindness is powerful, and it's that passion that Amanda aims to leverage for broader impact. The Welsh government's recent cancer plan aims to enhance access to new treatments for brain cancer, an encouraging step. However, if the funding trends continue, even these advancements might not trickle down effectively. Amanda's resolve to honor her daughter’s memory by advocating for change means that she’s not merely mourning—she's mobilizing. For anyone observing this situation, it’s impossible to underscore the importance of persistent advocacy in the face of systemic neglect. Change may be slow, but as Amanda proves, if even minor improvements can be made, they matter. And specifically for the realm of brain cancer research, that shift must happen sooner rather than later.